Invitae Corporation
OTC: NVTAQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Kenneth D. Knight
- Employees
- 1,700
- Headquarters
- San Francisco, United States
- IPO year
- 2015
- Market cap
- $85.9K
- Website
- https://www.invitae.com
Loading NVTAQ…
Loading profile data…Frequently asked questions about NVTAQ
What does Invitae Corporation (NVTAQ) do?
Invitae Corporation (NVTAQ) operates as a medical genetics enterprise, striving to advance healthcare outcomes by furnishing crucial genetic information to individuals across the United States, Canada, and other international markets. The company's diverse offerings include genetic diagnostic services for various clinical domains, such as heredi...
Where does NVTAQ trade?
Invitae Corporation (NVTAQ) trades on the Other OTC.
What sector is NVTAQ in?
Invitae Corporation (NVTAQ) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Invitae Corporation?
Kenneth D. Knight is the chief executive officer of Invitae Corporation (NVTAQ).
Where is Invitae Corporation headquartered?
Invitae Corporation is headquartered in United States.
Does NVTAQ pay a dividend?
Invitae Corporation (NVTAQ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NVTAQ go public?
Invitae Corporation (NVTAQ) completed its initial public offering in 2015.